Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
CORRECTION article
Corrigendum: Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Provisionally accepted- 1 Kidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
- 2 Key Laboratory of Nephropathy, Zhejiang Province, Hangzhou, Jiangsu Province, China
- 3 Institute of Translational Medicine, Zhejiang University of Medicine, Hangzhou, China
- 4 Institute of Nephropathy, Zhejiang University, Hangzhou, China
- 5 Department of Nephrology,The First People's Hospital of Wenling, Taizhou, China
A Corrigendum on Ren P, Lu L, Cai S, Chen J, Lin W andHan F (2021) Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease.Front. Immunol. 12:713540.doi: 10.3389/fimmu.2021.713540 Additional Affiliation(s) In the published article, there was an error regarding the affiliation for [Shasha Cai]. As well as having affiliation [4], she should also have [1]. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: Alternative Splicing, autoimmune disease, systemic lupus erythematosus, Rheumatoid arthritis, therapy
Received: 18 Oct 2024; Accepted: 31 Oct 2024.
Copyright: © 2024 Ren, Lu, Shasha, Chen, Lin and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Cai Shasha, Kidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Weiqiang Lin, Kidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Fei Han, Kidney Disease Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.